Skip to main content

Peer Review reports

From: CONFIRM: a double-blind, placebo-controlled phase III clinical trial investigating the effect of nivolumab in patients with relapsed mesothelioma: study protocol for a randomised controlled trial

Original Submission
21 Dec 2017 Submitted Original manuscript
20 Feb 2018 Author responded Author comments - Dean Fennell
Resubmission - Version 2
20 Feb 2018 Submitted Manuscript version 2
15 Mar 2018 Reviewed Reviewer Report - Shelley Potter
Resubmission - Version 3
Submitted Manuscript version 3
15 Mar 2018 Editorially accepted
18 Apr 2018 Article published 10.1186/s13063-018-2602-y

You can find further information about peer review here.

Back to article page